4D pharma (LBPSW) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. 4D pharma vs. 180 Life Sciences Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and 4D pharma (NASDAQ:LBPSW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Which has preferable earnings & valuation, ATNFW or LBPSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/A4D pharma$522KN/AN/AN/AN/A Does the media favor ATNFW or LBPSW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled 4D pharma'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral 4D pharma Neutral Does the MarketBeat Community favor ATNFW or LBPSW? 180 Life Sciences and 4D pharma both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/A4D pharmaN/AN/A Is ATNFW or LBPSW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A 4D pharma N/A N/A N/A Summary4D pharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LBPSW vs. The Competition Export to ExcelMetric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/AN/A$2.00B$7.63BDividend YieldN/AN/A2.75%4.33%P/E RatioN/AN/A22.1418.17Price / SalesN/AN/A55.72105.10Price / CashN/AN/A51.7234.62Price / BookN/AN/A1.964.19Net IncomeN/AN/A-$333.48M$247.59M 4D pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AATNFW180 Life SciencesN/A$0.01flatN/A-22.2%$0.00N/A0.007AEHAWAesther Healthcare AcquisitionN/A$0.03+9.1%N/A-74.2%$0.00N/A0.002Gap DownHigh Trading VolumeAIMDWAinosN/A$0.11+24.0%N/A+37.8%$0.00$20,729.000.0040Gap UpALVOWAlvotechN/A$1.40+26.1%N/A-58.8%$0.00$489.68M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.05-29.5%N/A-8.2%$0.00$37.32M0.0070BTMDWbioteN/A$0.01-2.3%N/A-93.2%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.14+7.8%N/A-84.7%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.04-3.3%N/A+9.4%$0.00$48.20M0.00220Gap DownCINGWCingulateN/A$0.04-17.8%N/A+146.7%$0.00N/A0.0020Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LBPSW) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.